Cetirizine Hydrochloride
Product Images NDC 68016-353

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Cetirizine Hydrochloride (NDC 68016-353). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chain Drug Consortium, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Label)

This is a package of Chewable Tablets intended for relief from indoor and outdoor allergies. The package contains 30 tablets for children who are six years and above. The tablets provide 24-hour relief from common allergy symptoms such as sneezing, runny nose, and itchy/watery eyes. The medication contains cetirizine hydrochloride and loratadine as the active ingredients. The document also contains a warning that the medication should not be used if the inner safety seal is missing or torn. Additionally, there are several illegible sections of text and characters.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.